Overview

4.5 out of 5 (22 Reviews)

Credits

1.00

Post Assessment Questions

5

Start Date

1 Jan 2021

Last Review Date

17 Aug 2023

Expiration Date

31 Dec 2023

Estimated Time To Finish

60 Minutes


 
Need Help?  If you have a system or content concerns, please contact support@statpearls.com

Activity Description

Viloxazine was marketed as an antidepressant in Europe for more than 2 decades under an immediate-release formulation before its potential as a treatment for patients with attention-deficit hyperactivity disorder (ADHD) was considered. Viloxazine received its first endorsement in the United Kingdom in 1971 and was subsequently recognized as an antidepressant in several other nations. However, commercial reasons led to its discontinuation in 2002. 

In April 2021, the U.S. Food and Drug Administration (FDA) approved viloxazine extended-release capsules for children and adolescents with ADHD. Research suggests that the mechanism of action of viloxazine is closely linked to inhibiting the reuptake of norepinephrine. Notably, the (S) stereoisomer of viloxazine exhibits 10 times greater potency than the (R) stereoisomer. This activity provides a comprehensive summary of the essential aspects of viloxazine therapy in the clinical setting, including indications, administration, doses, contraindications, mechanism of action, adverse events, and other crucial information relevant to the interprofessional team responsible for managing and treating ADHD in patients.


Target Audience

This activity has been designed to meet the educational needs of physicians.

Learning Objectives

At the conclusion of this activity, the learner will be better able to:

  • Identify viloxazine's pharmacological profile, mechanism of action, and unique properties compared to other ADHD medications.
  • Screen potential candidates for viloxazine therapy by conducting thorough assessments of their medical history, ADHD symptoms, and treatment response to determine suitability.
  • Assess the effectiveness and safety of viloxazine therapy through ongoing patient evaluation and monitoring of ADHD symptoms and potential adverse events.
  • Communicate effectively about the viloxazine treatment's rationale, potential benefits, risks, and expectations to ensure shared decision-making between patients, caregivers, and the healthcare team.

Disclosures

The Campbell University Jerry M. Wallace School of Osteopathic Medicine (CUSOM) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they or their immediate family may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by CUSOM for resolution, to ensure fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.

CUSOM will identify, review, and resolve all conflicts of interest that faculty, authors, activity directors, planners, managers, peer reviewers, or relevant staff disclose prior to an educational activity being delivered to learners. Disclosure of a relationship is not intended to suggest or condone bias in any presentation but is made to provide participants with information that might be of potential importance to their evaluation of a presentation. Disclosure information for authors, editors, planners, peer reviewers, and/or relevant staff is provided with this activity.

Continuing Education Accreditation Information

 

 

The Campbell University Jerry M. Wallace School of Osteopathic Medicine (CUSOM) is accredited by the American Osteopathic Association to provide osteopathic continuing medical education for physicians. CUSOM designates this enduring material for a maximum of 1.00 AOA Category 1 B Credits and will report CME credits commensurate with the extent of the physician's participation in the activity.

Cancellation Policy: Cancellations must be received in writing and a money back guarantee is provided if not completely satisfied.

  • StatPearls and CUSOM reserve the right to cancel any course due to unforeseen circumstances. StatPearls and CUSOM will not be responsible for other expenses incurred by the participant in the unlikely event that the program is canceled.

Equal Opportunity

  • StatPearls and CUSOM are Equal Opportunity / Affirmative Action / Equal Access Institutions. 

Medium or Media Used:

  • Computer Requirements:  Internet Access
  • E-mail Address

Instructions for Credit

  1. Register for the activity and create a StatPearls login.     
  2. Review the required accreditation information:  Target audience, learning objectives and disclosure information.
  3. Complete the entire self-study activity.
  4. Complete the post-test assessments.
  5. Successfully pass the post-test with a minimum score of 100%.
  6. Complete the evaluation form.
  7. Obtain a certificate.

StatPearls and CUSOM adheres to AOA Standards regarding commercial support of continuing medical education. It is the policy of StatPearls and Campbell that the faculty and planning committee disclose real or apparent conflicts of interest relating to the topics of this educational activity, that relevant conflict(s) of interest are resolved and also that authors and editors will disclose any unlabeled/unapproved use of drug(s) or device(s) during their presentation. Detailed disclosure will be made prior to starting the activity.

The information provided at this CME/CE activity is for continuing education purposes only and is not meant to substitute for the independent medical/clinical judgment of a healthcare provider relative to diagnostic and treatment options of a specific patient’s medical condition.

This course is intended for osteopathic physicians who wish to earn AOA CME credit. Take this version of the course to ensure you receive appropriate credit.

 

 
 

Reviews

Justin M. on 2/23/2022

Dr Haresh D. on 3/30/2022

Murchana K. on 9/28/2022

April D. on 10/14/2022

Natalie p. on 1/3/2023

Dr Jagveer S. on 4/9/2023

Cheryl M. on 6/6/2023

Kym D. on 7/6/2023

Sushma B. on 8/5/2023

Kimberly B. on 10/13/2023

Nivetha V. on 11/9/2023

Akshaya K. on 11/19/2023

Nida A. on 11/24/2023

Adithya nikhileshwar B. on 12/23/2023

Kasie C. on 1/25/2024

Joseph S. on 2/12/2024

Jibril Y. on 2/24/2024

Randall L. on 3/11/2024

Ejaz J. on 4/20/2024

Likta N. on 4/13/2024

Malani K. on 4/15/2024

Dr. Neha K. on 4/17/2024

Unlimited Physician CME

Stay up to date on the latest medical knowledge with 6673 CME activities. In these online self-assessment activities, read our reference articles and test your knowledge with more than 7923.5 hours of CME.

Learn About Lifetime CME

6 Month Unlimited Physician CME

Access to all the Unlimited Physician CME activities in all specialties.

$399 per half year per user

1 Year Unlimited Physician CME

Access to all the Unlimited Physician CME activities in all specialties.

$599 per 1 year per user